PEOPLE > Catherine K. Yeung, Pharm.D., Ph.D.

Catherine K. Yeung, Pharm.D., Ph.D.

Assistant Professor, Dept. of Pharmacy

Kidney Research Institute
University of Washington
Box 359606
325 9th ave
Seattle, WA 98104

P: 206-685-1075

F: 206-685-9399

E: cathyy@uw.edu

Education and Training

Pharm.D. (Pharmacy)
University of Michigan
Ann Arbor, MI


Ph.D. (Medicinal Chemistry)
University of Washington
Seattle, WA


Postdoctoral fellow (Pharmaceutical Chemistry)
University of Michigan
Ann Arbor, MI


Senior Fellow (Pharmaceutics)
University of Washington
Seattle, WA

MPH (Epidemiology)


University of Washington


Seattle, WA

Research Interests

Mechanisms of altered drug exposure in patients with kidney disease

Prediction of metabolically-based drug interactions

Microphysiologic models of the proximal and distal tubules

SELECTED PUBLICATIONS

Chang SY, Weber EJ, Sidorenko VS, Chapron A, Yeung CK, Gao C, Mao Q, Shen D, Wang J, Rosenquist TA, Dickman KG, Neumann T, Grollman AP, Kelly EJ, Himmelfarb J, Eaton DL., Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI insight. 2017; 2(22).

Chapron A, Shen DD, Kestenbaum BR, Robinson-Cohen C, Himmelfarb J, Yeung CK. Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis. Clinical and translational science. 2017; 10(5):395-403.

Robinson-Cohen C, Newitt R, Shen DD, Rettie AE, Kestenbaum BR, Himmelfarb J, Yeung CK. Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients. PloS one. 2016; 11(8).

Yeung CK, Shen DD, Thummel KE, Himmelfarb J. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport. Kidney international. 2014; 85(3):522-8.